Mechanistic description
CD33 is a microglial-specific sialic acid-binding receptor that regulates immune activation. Modulating CD33-mediated sialic acid recognition could fine-tune microglial responses to AD pathology and restore proper immune surveillance without excessive inflammation.
Debate provenance: derived from debate sess_SDA-2026-04-03-gap-seaad-20260402025452 on question: What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data? Use Allen Brain Cell Atlas evidence. Identify mechanisms of cell-type-specific vulnerability in AD pathology.. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms CD33, CD33-Sialic, Microglia, Modulation, Pathway, activation, microglial, modulation. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). CD33-Sialic Acid Pathway Modulation in Microglia. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-7db304c9a9d8
@misc{scidex_hypothesis_hdebate7,
title = {CD33-Sialic Acid Pathway Modulation in Microglia},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-7db304c9a9d8},
note = {SciDEX artifact hypothesis:h-debate-7db304c9a9d8}
}